Morphic Holding, Inc. announced two key executive appointments. Dr. Bruce Rogers has been named President and Dr. Blaise Lippa, has been named Chief Scientific Officer. Dr. Rogers previously served as Morphic's Chief Scientific Officer and Dr. Lippa served as Morphic's Senior Vice President and Head of Molecular Discovery.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
30.78 USD | -0.08% | +4.36% | +6.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.56% | 1.54B | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- MORF Stock
- News Morphic Holding, Inc.
- Morphic Holding, Inc. Announces Management Appointments